{"success":true,"data":{"pressRelease":{"id":"164862","rtpr_id":"nBw20krcba-20261008","ticker":"ZTS","exchange":"NYSE","all_tickers":["ZTS"],"title":"Zoetis Declares Fourth Quarter 2026 Dividend","author":"Business Wire","published_at":"2026-10-08T20:15:00.341Z","article_body":"Zoetis Declares Fourth Quarter 2026 Dividend\n\nThe Board of Directors of Zoetis Inc.\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.zoetis.com%2F&esheet=54617622&newsitemid=20261008035404&lan=en-US&anchor=Zoetis+Inc.&index=1&md5=80913b89e8bf1f63ce74ff7fd3854e72)\n(NYSE:ZTS) has declared a dividend of $0.53 per share for the fourth quarter\nof 2026. The dividend will be paid on Tuesday, December 1, 2026, to all\nholders of record of the Company’s common stock as of the close of business\non Friday, October 30, 2026.\n\nAbout Zoetis\n\nZoetis is the world’s leading animal health company, driven by a singular\npurpose: to nurture our world and humankind by advancing care for animals.\nWith a legacy of nearly 75 years, Zoetis continues to pioneer ways to predict,\nprevent, detect, and treat animal illness supporting veterinarians, livestock\nproducers and pet owners in over 100 countries. We integrate deep scientific\nexpertise, data-driven R&D, advanced manufacturing, and commercial\nexcellence to deliver meaningful innovation across medicines, vaccines,\ndiagnostics biopharmaceuticals, and digital solutions. Guided by our vision to\nbe the most trusted and valued animal health company, Zoetis is committed to\nsetting new standards for the future of animal care through innovation,\ncustomer obsession, and purpose-driven colleagues. To learn more, visit\nZoetis.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.zoetis.com%2F&esheet=54617622&newsitemid=20261008035404&lan=en-US&anchor=Zoetis.com&index=2&md5=cec9ca17309fa9f9e1326a35220e3568)\n.\n\nDISCLOSURE NOTICES\n\nForward-Looking Statements: This press release contains \"forward-looking\nstatements\" within the meaning of the Private Securities Litigation Reform Act\nof 1995. These forward-looking statements include, but are not limited to,\nstatements, which reflect the current views of Zoetis with respect to business\nplans or prospects, future operating or financial performance, future use of\ncash and dividend payments, and other future events. These statements are not\nguarantees of future performance or actions. Forward-looking statements are\nsubject to risks and uncertainties. If one or more of these risks or\nuncertainties materialize, or if management's underlying assumptions prove to\nbe incorrect, actual results may differ materially from those contemplated by\na forward-looking statement. Forward-looking statements speak only as of the\ndate on which they are made. Zoetis expressly disclaims any obligation to\nupdate or revise any forward-looking statement, whether as a result of new\ninformation, future events or otherwise. A further list and description of\nrisks, uncertainties and other matters can be found in our most recent Annual\nReport on Form 10-K, including in the sections thereof captioned\n“Forward-Looking Statements and Factors That May Affect Future Results”\nand “Item 1A. Risk Factors,” in our Quarterly Reports on Form 10-Q and in\nour Current Reports on Form 8-K. These filings and subsequent filings are\navailable online at www.sec.gov\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.sec.gov&esheet=54617622&newsitemid=20261008035404&lan=en-US&anchor=www.sec.gov&index=3&md5=d1af816c5fabea1a880f15b92e340138)\n, www.zoetis.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.zoetis.com&esheet=54617622&newsitemid=20261008035404&lan=en-US&anchor=www.zoetis.com&index=4&md5=e4d2cdd82597bf48fd52912364739733)\n, or on request from Zoetis.\n\nZTS-COR\n\nZTS-IR\n\nZTS-FIN\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20261008035404/en/\n(https://www.businesswire.com/news/home/20261008035404/en/)\n\nMedia Contacts:\n\nJennifer Albano\n\n1-862-399-0810 (o)\n\njennifer.albano@zoetis.com \n(mailto:jennifer.albano@zoetis.com) \n\n\nLaura Panza\n\n1-973-975-5176 (o)\n\nlaura.panza@zoetis.com \n(mailto:laura.panza@zoetis.com) \n\n\nInvestor Contacts:\n\nMathieu Aussermeier\n\n1-862-460-0181 (o)\n\nmathieu.aussermeier@zoetis.com \n(mailto:mathieu.aussermeier@zoetis.com) \n\n\nNick Soonthornchai\n\n1-973-443-2792 (o)\n\nnick.soonthornchai@zoetis.com (mailto:nick.soonthornchai@zoetis.com)\n\n \n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw20krcba-20261008","title":"Zoetis Declares Fourth Quarter 2026 Dividend","author":"Business Wire","ticker":"ZTS","created":"2026-10-08T20:15:00.341Z","tickers":["ZTS"],"exchange":"NYSE","article_body":"Zoetis Declares Fourth Quarter 2026 Dividend\n\nThe Board of Directors of Zoetis Inc.\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.zoetis.com%2F&esheet=54617622&newsitemid=20261008035404&lan=en-US&anchor=Zoetis+Inc.&index=1&md5=80913b89e8bf1f63ce74ff7fd3854e72)\n(NYSE:ZTS) has declared a dividend of $0.53 per share for the fourth quarter\nof 2026. The dividend will be paid on Tuesday, December 1, 2026, to all\nholders of record of the Company’s common stock as of the close of business\non Friday, October 30, 2026.\n\nAbout Zoetis\n\nZoetis is the world’s leading animal health company, driven by a singular\npurpose: to nurture our world and humankind by advancing care for animals.\nWith a legacy of nearly 75 years, Zoetis continues to pioneer ways to predict,\nprevent, detect, and treat animal illness supporting veterinarians, livestock\nproducers and pet owners in over 100 countries. We integrate deep scientific\nexpertise, data-driven R&D, advanced manufacturing, and commercial\nexcellence to deliver meaningful innovation across medicines, vaccines,\ndiagnostics biopharmaceuticals, and digital solutions. Guided by our vision to\nbe the most trusted and valued animal health company, Zoetis is committed to\nsetting new standards for the future of animal care through innovation,\ncustomer obsession, and purpose-driven colleagues. To learn more, visit\nZoetis.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.zoetis.com%2F&esheet=54617622&newsitemid=20261008035404&lan=en-US&anchor=Zoetis.com&index=2&md5=cec9ca17309fa9f9e1326a35220e3568)\n.\n\nDISCLOSURE NOTICES\n\nForward-Looking Statements: This press release contains \"forward-looking\nstatements\" within the meaning of the Private Securities Litigation Reform Act\nof 1995. These forward-looking statements include, but are not limited to,\nstatements, which reflect the current views of Zoetis with respect to business\nplans or prospects, future operating or financial performance, future use of\ncash and dividend payments, and other future events. These statements are not\nguarantees of future performance or actions. Forward-looking statements are\nsubject to risks and uncertainties. If one or more of these risks or\nuncertainties materialize, or if management's underlying assumptions prove to\nbe incorrect, actual results may differ materially from those contemplated by\na forward-looking statement. Forward-looking statements speak only as of the\ndate on which they are made. Zoetis expressly disclaims any obligation to\nupdate or revise any forward-looking statement, whether as a result of new\ninformation, future events or otherwise. A further list and description of\nrisks, uncertainties and other matters can be found in our most recent Annual\nReport on Form 10-K, including in the sections thereof captioned\n“Forward-Looking Statements and Factors That May Affect Future Results”\nand “Item 1A. Risk Factors,” in our Quarterly Reports on Form 10-Q and in\nour Current Reports on Form 8-K. These filings and subsequent filings are\navailable online at www.sec.gov\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.sec.gov&esheet=54617622&newsitemid=20261008035404&lan=en-US&anchor=www.sec.gov&index=3&md5=d1af816c5fabea1a880f15b92e340138)\n, www.zoetis.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.zoetis.com&esheet=54617622&newsitemid=20261008035404&lan=en-US&anchor=www.zoetis.com&index=4&md5=e4d2cdd82597bf48fd52912364739733)\n, or on request from Zoetis.\n\nZTS-COR\n\nZTS-IR\n\nZTS-FIN\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20261008035404/en/\n(https://www.businesswire.com/news/home/20261008035404/en/)\n\nMedia Contacts:\n\nJennifer Albano\n\n1-862-399-0810 (o)\n\njennifer.albano@zoetis.com \n(mailto:jennifer.albano@zoetis.com) \n\n\nLaura Panza\n\n1-973-975-5176 (o)\n\nlaura.panza@zoetis.com \n(mailto:laura.panza@zoetis.com) \n\n\nInvestor Contacts:\n\nMathieu Aussermeier\n\n1-862-460-0181 (o)\n\nmathieu.aussermeier@zoetis.com \n(mailto:mathieu.aussermeier@zoetis.com) \n\n\nNick Soonthornchai\n\n1-973-443-2792 (o)\n\nnick.soonthornchai@zoetis.com (mailto:nick.soonthornchai@zoetis.com)\n\n \n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-10-08T20:15:00.375438594Z","server_sent_at_ms":1791490500375},"received_at":"2026-10-08T20:15:00.442Z","source_url":"https://www.businesswire.com/news/home/20261008035404/en/"},"analysis":{"id":"153269","press_release_id":"164862","analysis_json":{"industry":{"label":"Pharmaceuticals, Biotechnology & Life Sciences","sector":"Health Care"},"redFlags":[],"eventType":"dividend","narrative":"Zoetis' board declared a Q4 2026 dividend of $0.53 per share.\n\nPayment is set for December 1, 2026, to holders of record as of October 30, 2026.\n\nThe declaration maintains the existing dividend level with no policy change announced.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine quarterly dividend declaration at $0.53 per share."},"keyFigures":{"customDimensions":{"payment_date":"2026-12-01","dividend_per_share":"$0.53","ex_dividend_record_date":"2026-10-30"}},"namedEntities":{"people":[],"products":[],"companies":[{"name":"Zoetis Inc.","ticker":"ZTS","relationship":"filer"}],"dollarAmounts":[{"amount":"$0.53","context":"per-share Q4 2026 dividend"}]},"materialImpact":{"score":1,"reasoning":"Routine quarterly dividend declaration with no change in amount or policy announced. Boilerplate capital-return update."},"tickerRelevance":{"others":[],"primary":"ZTS"},"globalImportance":10,"audienceRelevance":30,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"large-cap","eventGravity":"routine-dividend-declaration","householdBrandBoost":"moderate"}},"event_type":"dividend","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Zoetis' board declared a Q4 2026 dividend of $0.53 per share.\n\nPayment is set for December 1, 2026, to holders of record as of October 30, 2026.\n\nThe declaration maintains the existing dividend level with no policy change announced.","key_figures":{"customDimensions":{"payment_date":"2026-12-01","dividend_per_share":"$0.53","ex_dividend_record_date":"2026-10-30"}},"named_entities":{"people":[],"products":[],"companies":[{"name":"Zoetis Inc.","ticker":"ZTS","relationship":"filer"}],"dollarAmounts":[{"amount":"$0.53","context":"per-share Q4 2026 dividend"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-08T20:15:08.006Z","global_importance":10,"audience_relevance":30,"importance_components":{"tickerTier":"large-cap","eventGravity":"routine-dividend-declaration","householdBrandBoost":"moderate"}},"durationMs":3511,"modelName":"glm-5.3-flashx"}}